Posted on November 13, 2024 / / Carl Bateson EVALUATING METACOGNITIVE THERAPY TO IMPROVE TREATMENT OF ANXIETY AND DEPRESSION IN CARDIOVASCULAR DISEASE THE NIHR FUNDED PATHWAY RESEARCH PROGRAMME Feasibility Study, PATHWAY Read More
Posted on November 13, 2024 / / Carl Bateson METACOGNITIVE THERAPY HOME-BASED SELF-HELP FOR CARDIAC REHABILITATION PATIENTS EXPERIENCING ANXIETY AND DEPRESSIVE SYMPTOMS: STUDY PROTOCOL FOR A FEASIBILITY RANDOMISED CONTROLLED TRIAL (PATHWAY HOME-MCT) Feasibility Study, PATHWAY Read More
Posted on November 13, 2024 / / Carl Bateson METACOGNITIVE THERAPY SELF-HELP FOR ANXIETY-DEPRESSION: SINGLE-BLIND RANDOMIZED FEASIBILITY TRIAL IN CARDIOVASCULAR DISEASE Feasibility Study, PATHWAY Read More
Posted on November 13, 2024 / / Carl Bateson ESTABLISHING THE FEASIBILITY OF GROUP METACOGNITIVE THERAPY FOR ANXIETY AND DEPRESSION IN CARDIAC REHABILITATION: A SINGLE-BLIND RANDOMIZED PILOT STUDY Feasibility Study, PATHWAY Read More
Posted on September 22, 2023 / / Carl Bateson YOUTH METACOGNITIVE THERAPY (YOMETA): PROTOCOL FOR A SINGLE-BLIND RANDOMISED FEASIBILITY TRIAL OF A TRANSDIAGNOSTIC INTERVENTION VERSUS TREATMENT AS USUAL IN 11-16-YEAR-OLDS WITH COMMON MENTAL HEALTH PROBLEMS Feasibility Study, YoMeta Read More
